Sano Genetics, a Cambridge-based research start-up, has secured £500,000 in seed funding for its platform which powers research into common disorders like depression and diabetes, as well as rare ones such as muscular dystrophy.
The NIH has awarded inaugural funding to three institutions to establish a new genome centre for the All of Us Research Program.
Rady Children’s Hospital has launched a new, California State-funded initiative called Project Baby Bear to cover rWGS for critically ill newborns across the state.
US representatives are pressing genetic testing companies for details on their security systems and customer privacy policies.
Even in light of the rising fears of “superbugs” in the world of big pharma, the marginal profits made through the development of antibiotics isn’t enough to justify the research.
Chinese investors have poured more money into the US biotech market in the first six months of 2018 than they did in the entirety of last year.
Helix has announced raising $200M in Series B funding, the expansion of the executive team with a new CFO, CMO, and CPO, the acquisition of HumanCode, and a new Denver office.
The California State Legislature has approved a budget including $2 million for a pilot project to fund clinical whole genome sequencing as a first line diagnostic test.
Non-profit Bill & Melinda Gates Medical Research Institute (MRI) has officially been launched, creating a new vision for drug development with a clear focus on the millions of people that die annually from contracting malaria, tuberculosis and diarrheal diseases.
Despite the availability of hepatitis C treatment and changes in restrictions of these therapies, private insurance companies and even public payers like Medicaid and Medicare are still refusing to pay for it.